Literature DB >> 9665954

Collection of cervical secretions does not adversely affect Pap smears taken immediately afterward.

A Hildesheim1, M C Bratti, R P Edwards, M Schiffman, A C Rodriguez, R Herrero, M Alfaro, L A Morera, S V Ermatinger, B T Miller, P A Crowley-Nowick.   

Abstract

Collection of cervical secretions for local immunological assessment requires that the secretions be collected prior to the Pap smear to avoid contamination with blood. The objective of the present study was to determine whether gentle collection of cervical secretions prior to a Pap smear collection influences the quality of the Pap smear. A total of 266 women were recruited. Half of the participants were assigned to collection of cervical secretions prior to Pap smear collection with Weck-cel sponges. The remaining half had only the Pap smear collection performed. Pap smear slides were reviewed and evaluated for quality by the Bethesda System adequacy criteria without knowledge of randomization. The proportions of limited or inadequate slides in the two study groups were compared by using the Pearson chi-square test. No significant differences were observed between the two study groups when overall Pap smear quality was evaluated (P = 0.29). Comparison of the two study groups with respect to individual adequacy criteria, including presence of air drying artifact, presence of obscuring blood, absence of metaplastic or endocervical cells from the transformation zone, scant cellularity, and presence of obscuring inflammatory cells, also revealed no significant differences between the two study groups. Results from the present study suggest that the collection of cervical secretions with Weck-cel sponges does not adversely impact the quality of subsequently obtained Pap smears.

Entities:  

Mesh:

Year:  1998        PMID: 9665954      PMCID: PMC95605          DOI: 10.1128/CDLI.5.4.491-493.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  15 in total

1.  Rectal immunization for induction of specific antibody in the genital tract of women.

Authors:  P A Crowley-Nowick; M C Bell; R Brockwell; R P Edwards; S Chen; E E Partridge; J Mestecky
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women.

Authors:  A Quesnel; S Cu-Uvin; D Murphy; R L Ashley; T Flanigan; M R Neutra
Journal:  J Immunol Methods       Date:  1997-03-28       Impact factor: 2.303

3.  Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.

Authors:  R Herrero; M H Schiffman; C Bratti; A Hildesheim; I Balmaceda; M E Sherman; M Greenberg; F Cárdenas; V Gómez; K Helgesen; J Morales; M Hutchinson; L Mango; M Alfaro; N W Potischman; S Wacholder; C Swanson; L A Brinton
Journal:  Rev Panam Salud Publica       Date:  1997-05

4.  Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.

Authors:  R J Kurman; D E Henson; A L Herbst; K L Noller; M H Schiffman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

5.  Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.

Authors:  T Tsukui; A Hildesheim; M H Schiffman; J Lucci; D Contois; P Lawler; B B Rush; A T Lorincz; A Corrigan; R D Burk; W Qu; M A Marshall; D Mann; M Carrington; M Clerici; G M Shearer; D P Carbone; D R Scott; R A Houghten; J A Berzofsky
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

6.  Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.

Authors:  A Hildesheim; M H Schiffman; T Tsukui; C A Swanson; J Lucci; D R Scott; A G Glass; B B Rush; A T Lorincz; A Corrigan; R D Burk; K Helgesen; R A Houghten; M E Sherman; R J Kurman; J A Berzofsky; T R Kramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-10       Impact factor: 4.254

7.  Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays.

Authors:  L Bélec; D Meillet; M Lévy; A Georges; C Tévi-Bénissan; J Pillot
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

8.  Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections.

Authors:  R L Ashley; L Corey; J Dalessio; P Wilson; M Remington; G Barnum; P Trethewey
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

9.  Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.

Authors:  B Haneberg; D Kendall; H M Amerongen; F M Apter; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

10.  Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination.

Authors:  J P Bouvet; L Bélec; R Pirès; J Pillot
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  6 in total

1.  Optimization of the weck-Cel collection method for quantitation of cytokines in mucosal secretions.

Authors:  L C Rohan; R P Edwards; L A Kelly; K A Colenello; F P Bowman; P A Crowley-Nowick
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Correlates of IL-10 and IL-12 concentrations in cervical secretions.

Authors:  Patti E Gravitt; Allan Hildesheim; Rolando Herrero; Mark Schiffman; Mark E Sherman; M Concepcion Bratti; Ana C Rodriguez; Lidia A Morera; Fernando Cardenas; Frederick P Bowman; Keerti V Shah; Peggy A Crowley-Nowick
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

3.  Papanicolaou smears: to swab or not to swab.

Authors:  Narpinder Hans; Andrew J Cave; Olga Szafran; Gordon Johnson; Ann Glass; G Richard Spooner; Philip J Klemka; Shirley Schipper
Journal:  Can Fam Physician       Date:  2007-08       Impact factor: 3.275

4.  Comparison of ophthalmic sponges for measurements of immune markers from cervical secretions.

Authors:  Philip E Castle; Ana-Cecilia Rodriguez; Frederick P Bowman; Rolando Herrero; Mark Schiffman; M Concepcion Bratti; Lidia Ana Morera; Danny Schust; Peggy Crowley-Nowick; Allan Hildesheim
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

5.  Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.

Authors:  Lotta Wassen; Marianne Jertborn
Journal:  Clin Vaccine Immunol       Date:  2006-02

Review 6.  Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature.

Authors:  Jade Pattyn; Severien Van Keer; Wiebren Tjalma; Veerle Matheeussen; Pierre Van Damme; Alex Vorsters
Journal:  Papillomavirus Res       Date:  2019-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.